Literature DB >> 15726055

The mortality of untreated pulmonary embolism in emergency department patients.

Kirsten K Calder1, Mel Herbert, Sean O Henderson.   

Abstract

Much of the literature on pulmonary embolism that is commonly referenced by emergency physicians begins with statistics concerning how often the diagnosis is missed and the lethality of pulmonary embolism if undiagnosed and untreated. It is likely that many emergency physicians continue to pursue an aggressive diagnostic strategy even in low-risk patients because of concerns about the potential for poor patient outcome and the medicolegal consequences of a missed diagnosis. The believed and often-quoted mortality and recurrence rates for untreated or missed pulmonary embolism are 26% to 30%. However, these figures originate from investigations that have little relevance to modern emergency medicine, which include studies dating to the 1940s, many of which have significant methodologic pitfalls. These data are also based primarily on either inpatient or autopsy populations, neither of which is representative of patients treated in the emergency department (ED). Analysis of untreated or missed pulmonary embolism in ambulatory patients reveals mortality and recurrence rates of less than 5%. This article discusses the background of commonly quoted pulmonary embolism statistics and highlights the need for future investigations enrolling ED patients that focus on disease outcome in this population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15726055     DOI: 10.1016/j.annemergmed.2004.10.001

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  27 in total

1.  Patients with an intermediate or high risk of a pulmonary embolism continue to pose a diagnostic challenge.

Authors:  D Grant; P Rosen
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

2.  Pulmonary CTA in sickle cell patients: quantitative assessment of enhancement quality.

Authors:  Jeff Jensen; Tony Lin; Elliot K Fishman; Pamela T Johnson
Journal:  Emerg Radiol       Date:  2017-08-11

3.  Muddy clinical waters: a missed pulmonary embolus.

Authors:  Nathaniel Lee; Simon Rupert Bax
Journal:  BMJ Case Rep       Date:  2014-03-12

Review 4.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Blood Adv       Date:  2019-11-26

Review 5.  Dabigatran etexilate: a review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence.

Authors:  Sarah L Greig; Kate McKeage
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

6.  Computer-aided detection and visualization of pulmonary embolism using a novel, compact, and discriminative image representation.

Authors:  Nima Tajbakhsh; Jae Y Shin; Michael B Gotway; Jianming Liang
Journal:  Med Image Anal       Date:  2019-08-06       Impact factor: 8.545

7.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

8.  Early anticoagulation is associated with reduced mortality for acute pulmonary embolism.

Authors:  Sean B Smith; Jeffrey B Geske; Jennifer M Maguire; Nicholas A Zane; Rickey E Carter; Timothy I Morgenthaler
Journal:  Chest       Date:  2010-01-15       Impact factor: 9.410

9.  Suboptimal CT pulmonary angiography in the emergency department: a retrospective analysis of outcomes in a large academic medical center.

Authors:  David D B Bates; Jaroslaw N Tkacz; Christina A LeBedis; Nagaraj Holalkere
Journal:  Emerg Radiol       Date:  2016-07-27

10.  Unsuspected pulmonary embolism in observation unit patients.

Authors:  Alexander T Limkakeng; Seth W Glickman; Charles B Cairns; Abhinav Chandra
Journal:  West J Emerg Med       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.